Stockreport

MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

MediWound Ltd. - Ordinary Shares  (MDWD) 
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mediwound.com/press-releases
PDF YAVNE, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully-integrated biopharmaceutical company focused on next-generation b [Read more]